To evaluate the performance of a new ablative 1940 nm pulsed laser developed by Laser Team Medical (LTM), designed for precise skin resurfacing and rejuvenation using Thulium-doped Yttrium Aluminum Perovskite (Tm:YAP) crystal. This laser delivers highly focused, ultra-short pulses that create minimal damage to surrounding tissue.
The novel 1940 nm pulsed laser shows promising safety and efficacy as the first ablative laser of its kind. It creates ultra-thin microcolumns with customizable coagulation, enhancing both dermal remodeling and surface skin rejuvenation, with reduced downtime. Its unique properties could significantly expand treatment options in dermatology and cosmetic medicine.
To evaluate the safety and preliminary efficacy of the Epicare 1940 nm Tm:YAP fractional ablative laser in a swine model, with a focus on epidermal regeneration, inflammation, collagen remodeling, and overall tissue healing.
This preclinical study confirms the safety and promising healing properties of the Epicare 1940 nm Tm:YAP laser for fractional skin ablation. The laser effectively creates precise microcolumns with minimal surrounding tissue damage and rapid tissue recovery.
However, further clinical trials in humans are necessary to optimize treatment protocols and fully validate efficacy across diverse skin types and conditions.